Company
OrganiGram Holdings
CVE:OGI
Headquartered in Moncton, NB, ORGANIGRAM, Inc. specializes in the production of Condition Specific Medical Marihuana under license from Health Canada. Our company is subject to the Marihuana for Medical Purposes Regulation (MMPR), including the Good Manufacturing Practices as well as the security directives as defined by the Office of Controlled Substances.
24 stories · page 1 of 2
Buds & Duds: Investors cheer as Organigram doubles revenue, beats expectations in quarterly results
Organigram soared lifting major cannabis indices into the green
Buds & Duds: Cannabis stocks stumble on Monday as CannTrust shares sink on Health Canada tussle over non-compliant grow rooms
Also on the move were Canopy Growth, TILT Holdings, 1933 Industries and OrganiGram
Buds & Duds: Cannabis stocks continue to make progress; TGOD shares shine on launch of global strategic hemp division
Also on the move were OrganiGram, Innovative Industrial Properties, Auxly and Terra Tech
Buds & Duds: Cannabis stocks take a breather; OrganiGram shares soar as it announces uplisting
Also on the move were The Supreme Cannabis Company, cbdMD, Namaste, TILT and Golden Leaf
Buds & Duds: Cannabis stocks slide on Tuesday; Sunniva shares sink on disappointing earnings
Also on the move were Tilray, HEXO, Redfund Capital, OrganiGram, The Green Organic Dutchman Holdings and HEXO
Buds & Duds: Cannabis stocks flat on Monday; EnWave shares continue to jump on Aurora deal
Also on the move were Valens GroWorks, HEXO, Aurora, Tilray, Aleafia, Aphria and OrganiGram
Buds & Duds: Cannabis stocks slide steeply as investors pause; 1933 Industries shares pop on Nevada licensing deal
Also on the move were RedFund Capital, Planet 13 Holdings, Isodiol International and OrganiGram
Valens cites significant boost in annual extraction capacity for dried cannabis and hemp
The company has reached multiyear extraction agreements with Canopy Growth, Tilray, OrganiGram and Green Organic Dutchman
Buds & Duds: Cannabis stocks on roller coaster, with GW Pharmaceuticals notching biggest gains
Cannabis stocks swung between gains and losses Wednesday
Valens GroWorks inks multi-year, renewable cannabis extraction agreement with Tilray Canada
Valens will provide cannabis and hemp extraction services to Tilray, a global leader in cannabis research, cultivation, production and distribution
Buds & Duds: Cannabis stocks pop as Aurora Cannabis pushes into Portugal
Aurora has agreed to acquire a 51% stake in Portugal's Gaia Pharma Lda, which will be renamed Aurora Portugal
Archive
Buds & Duds: Namaste shares jump on settlement with former CEO Sean Dollinger
Dollinger dropped his lawsuit and will now serve as a senior advisor at the Toronto company following his ouster
Buds & Duds: High times for The Green Organic Dutchman after winning cultivation license in Denmark
The North American Marijuana Index, which tracks leading cannabis companies in the US and Canada, fell 1.8% to 278.10 in early trade
Valens GroWorks signs multi-year cannabis extraction agreement with Organigram
Valens will extract cannabis flowers and trim from Organigram's Moncton operation as well as hemp to produce extract concentrate
Archive
Buds & Duds: Namaste shares tick higher after Israel's Parliament approves medical cannabis exports
The Israeli government has approved the export of Israeli-grown medical cannabis to countries where it's legal